1. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition
   Aroa Baragaño Raneros et al, 2017, Oncotarget CrossRef
2. Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention
   Aroa Baragaño Raneros et al, 2014, OncoImmunology CrossRef
3. Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia
   A Baragaño Raneros et al, 2015, Genes & Immunity CrossRef
4. Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer
   Eun-Kyoung Koh et al, 2023, Scientific Reports CrossRef
5. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells
   Jens Mattern et al, 2019, Scientific Reports CrossRef
6. Soluble MICA is elevated in pancreatic cancer: Results from a population based case‐control study
   Guillaume Onyeaghala et al, 2017, Molecular Carcinogenesis CrossRef
7. Transforming Growth Factor TGFβ Increases Levels of Microtubule-Associated Protein MAP1S and Autophagy Flux in Pancreatic Ductal Adenocarcinomas
   Kun Song et al, 2015, PLOS ONE CrossRef
8. Glycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune Recognition
   Sheila López-Cobo et al, 2016, Frontiers in Cell and Developmental Biology CrossRef
9. Identification of membrane proteins regulated by ADAM15 by SUSPECS proteomics
   Matteo Calligaris et al, 2023, Frontiers in Molecular Biosciences CrossRef
10. jSRC: a flexible and accurate joint learning algorithm for clustering of single-cell RNA-sequencing data
    Wenming Wu et al, 2021, Briefings in Bioinformatics CrossRef
11. Adamalizyny jako potencjalne biomarkery w wybranych nowotworach złośliwych przewodu pokarmowego
    Magdalena Sikora-Skrabaka et al, 2021, Postępy Higieny i Medycyny Doświadczalnej CrossRef